(VIANEWS) – SOLVAY (SOLB.BR), CTAC (CTAC.AS), SANOFI (SAN.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. SOLVAY (SOLB.BR)
350% Payout Ratio
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, SOLVAY has a trailing twelve months EPS of €1.18.
PE Ratio
SOLVAY has a trailing twelve months price to earnings ratio of 28.14. Meaning, the purchaser of the share is investing €28.14 for every euro of annual earnings.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 3, 2024, the estimated forward annual dividend rate is 1.62 and the estimated forward annual dividend yield is 4.81%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 82.6% and a negative 80%, respectively.
Yearly Top and Bottom Value
SOLVAY’s stock is valued at €33.20 at 12:10 EST, below its 52-week high of €36.62 and way above its 52-week low of €17.90.
More news about SOLVAY.
2. CTAC (CTAC.AS)
171.43% Payout Ratio
Ctac N.V. provides business and cloud integration solutions primarily in the Netherlands and Belgium. The company provides XV Retail Suite, a POS solution for centrally controlled B2B and B2C food and non-food retailers; Fit4 Real Estate, a solution for the commercial real estate markets; Ommi Customer Loyalty, a loyalty platform for retailers and wholesalers for turning ordinary customers into loyal fans; Ctac Private Cloud, a cloud environment for organizations' cloud infrastructure and applications; Pricing & Promotion Engine that calculates the correct item price for each individual customer, taking into account personal promotions, customer segments, loyalty cards and vouchers; Floating Basket, which offers a cross-channel and cross-device shopping experience with ease using a customer-specific shopping basket; and ETIM extension for inriver PIM for documenting technical and commercial product characteristics. It offers other software solutions comprising Amazon Web Services, Data Sync Manager, Ometa, Bynder DAM, Winshuttle, Winshuttle Evolve, S/4Move, and Inriver PIM platforms; SAP solutions, including SAP Data Warehouse Cloud, SAP Security Assessment, SAP Fiori, SAP S/4HANA, SAP ECC, SAP Business Warehouse, SAP Analytics Cloud, and SAP EWM; and Microsoft solutions, such as Microsoft Azure Public Cloud, Microsoft Security Assessment, Microsoft Teams, Route365 Cooker Session, Microsoft SharePoint, and Microsoft 365. In addition, the company offers integrated, technical, and functional application management; programme and change management; agile consultancy; cloud and technology consultancy, advice and support; implementation; servicedesk and coordination management; and license and spend management services, as well as resourcing solutions. It primarily serves retail, wholesale, manufacturing, real estate, and cross industries. Ctac N.V. was founded in 1992 and is based in s-Hertogenbosch, the Netherlands.
Earnings Per Share
As for profitability, CTAC has a trailing twelve months EPS of €0.07.
PE Ratio
CTAC has a trailing twelve months price to earnings ratio of 45.14. Meaning, the purchaser of the share is investing €45.14 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.82%.
More news about CTAC.
3. SANOFI (SAN.PA)
98.61% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Sales Growth
SANOFI’s sales growth for the next quarter is 7.3%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 9.2% and positive 1.6% for the next.
Moving Average
SANOFI’s worth is higher than its 50-day moving average of €88.97 and under its 200-day moving average of €92.14.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.99%.
More news about SANOFI.
4. MULTICONSULT (MULTI.OL)
96.57% Payout Ratio
Multiconsult ASA, together with its subsidiaries, engages in the provision of engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy services in the areas, including design, planning, project supervision and management, geotechnical and environmental site surveys, and verification and control; and provides analysis and due diligence, design and construction management, environmental services and HSE, geology and geotechnical study, green bond, hydrometry and hydrological field work, lenders advisory, renewable energy tender, and river basin management services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. The company was founded in 1908 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MULTICONSULT has a trailing twelve months EPS of kr9.32.
PE Ratio
MULTICONSULT has a trailing twelve months price to earnings ratio of 16.47. Meaning, the purchaser of the share is investing kr16.47 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.55%.
Volume
Today’s last reported volume for MULTICONSULT is 1122 which is 94.2% below its average volume of 19358.
Yearly Top and Bottom Value
MULTICONSULT’s stock is valued at kr153.50 at 12:10 EST, below its 52-week high of kr169.00 and way higher than its 52-week low of kr117.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 4.8B for the twelve trailing months.
Moving Average
MULTICONSULT’s worth is above its 50-day moving average of kr142.46 and way higher than its 200-day moving average of kr134.60.
More news about MULTICONSULT.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Sales Growth
1’s sales growth is 1% for the current quarter and 1% for the next.
More news about 1.
